Genonto is the leader in genetic sequencing to detect genes linked to opioid dependency and other dependence diseases. The mobile platform uses a proprietary methodology to examine the whole exome (WES) for detecting the presence of those genes which indicate a person is at risk for developing addictions and dependencies with the goal of preventative strategies.
Why We Are Different
First Problem on Our List
Solution to the First Problem
Be the first to know about our upcoming national launch!